MPH

Equitable Breakthroughs in Medicine Development Reaches Next Phase Driving Diversity in Clinical Trials in Georgia, South Carolina, Tennessee, and Texas

Retrieved on: 
Monday, February 26, 2024

NEW HAVEN, Conn., Feb. 26, 2024 /PRNewswire/ -- Equitable Breakthroughs in Medicine Development (EQBMED), led by Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center (RCMI) at Morehouse School of Medicine, and Vanderbilt University Medical Center, is a partnership bringing clinical trial sites closer to the community to further equity and access for diverse populations. Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities. The partnerships include:

Key Points: 
  • Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities.
  • The program works to increase awareness of clinical trials, address misinformation and historical mistrust, while ensuring the trial is easily accessible.
  • The EQBMED partnership meets sites where they are, building on their strengths and capabilities to become sustainable within the clinical trial ecosystem.
  • "EQBMED is making real progress towards equitable access to clinical trials and enhancing these sites with needed resources."

Smriti Kirubanandan Appointed Managing Director of Accenture's Healthcare Practice

Retrieved on: 
Sunday, February 25, 2024

SAN FRANCISCO, Feb. 25, 2024 /PRNewswire-PRWeb/ -- Smriti Kirubanandan is an Indian-American Healthcare Business Executive who is joining Accenture as Managing Director of the firm's healthcare practice.

Key Points: 
  • Smriti Kirubanandan is an Indian-American Healthcare Business Executive who is joining Accenture as Managing Director of the firm's healthcare practice.
  • SAN FRANCISCO, Feb. 25, 2024 /PRNewswire-PRWeb/ -- Smriti Kirubanandan is an Indian-American Healthcare Business Executive who is joining Accenture as Managing Director of the firm's healthcare practice.
  • Smriti Kirubanandan, aged 36, emerges as a contemporary Renaissance figure, achieving significant milestones as a Growth and Partnerships Executive with a distinctive background in Robotics and Public Health.
  • In recognition of her outstanding contributions, the World Economic Forum bestowed upon Smriti Kirubanandan the title of Young Global Leader in 2023.

BayCare Names Three to Vice President Roles; Creates New Surgical Services Vice President Position

Retrieved on: 
Thursday, February 22, 2024

The health system has also created a new vice president of perioperative services position to lead surgical services initiatives across BayCare's 16 hospitals.

Key Points: 
  • The health system has also created a new vice president of perioperative services position to lead surgical services initiatives across BayCare's 16 hospitals.
  • "It is my privilege to announce the naming of three long-time BayCare team members to vice president roles," said BayCare's Chief Team Resources Officer Kyle Barr.
  • Angel Brown has been promoted to vice president of talent acquisition and inclusion.
  • BayCare has announced plans to build a 17th hospital in Manatee County, where it already has doctor's offices, and it delivers home care services across 13 counties.

New Leadership for Eating Disorders Treatment Facilitators Task Force

Retrieved on: 
Wednesday, February 21, 2024

PEKIN, Ill., Feb. 21, 2024 /PRNewswire/ -- The International Association of Eating Disorders Professionals (iaedp™) has two new leaders of the Eating Disorders Treatment Facilitator (EDTF) Task Force: Angela Storck-Peterson, MPH, MS, RD, LDN, CEDS, and Kimberly Cover, Kimberly Wright Cover, MS, LPC, RD, CEDS-C, CSSD, LDN.

Key Points: 
  • PEKIN, Ill., Feb. 21, 2024 /PRNewswire/ -- The International Association of Eating Disorders Professionals (iaedp™) has two new leaders of the Eating Disorders Treatment Facilitator (EDTF) Task Force: Angela Storck-Peterson, MPH, MS, RD, LDN, CEDS, and Kimberly Cover, Kimberly Wright Cover, MS, LPC, RD, CEDS-C, CSSD, LDN.
  • The EDTF Task Force was developed to connect primary care medical providers with experienced eating disorders professionals to help treat their patients in early identification, assessment and treatment.
  • Key EDTF Task Force services are:
    Specialized education in screening and recognizing early signs of eating disorders.
  • "Clinicians are key in early identification and treatment of patients with disordered eating, excessive exercise, as well as eating disorders.

CHA Hollywood Presbyterian Medical Center Ranked No. 2 in California for Coronary Intervention by Healthgrades for Two Years in a Row

Retrieved on: 
Wednesday, February 21, 2024

LOS ANGELES, Feb. 21, 2024 /PRNewswire-PRWeb/ -- CHA Hollywood Presbyterian Medical Center (CHA HPMC), a member of CHA Health Systems, a global network providing a full spectrum of dynamic healthcare services, has been ranked as the second-best hospital in California for coronary interventional procedures for two consecutive years, according to a new analysis released by Healthgrades, the leading online resource that connects consumers, physicians, and health systems. This achievement reflects CHA HPMC's commitment to delivering the best care possible and distinguishes the organization as one of California's leading hospitals for Coronary Intervention.

Key Points: 
  • This achievement reflects CHA HPMC's commitment to delivering the best care possible and distinguishes the organization as one of California's leading hospitals for Coronary Intervention.
  • "At CHA HPMC, the well-being and safety of our patients stand as our foremost priority, and this recognition emphasizes our dedication to delivering exceptional and safe healthcare."
  • Healthgrades evaluates hospitals solely on what matters most–patient outcomes–to determine the top-performing hospitals for specialty care in each of the 32 states assessed.
  • *
    *Statistics are based on Healthgrades analysis of MedPAR data for years 2020 through 2022 and represent three-year estimates for Medicare patients only.

The Angelman Syndrome Foundation (ASF) and Cedars-Sinai Guerin Children's team up to launch new clinic for families living with Angelman syndrome

Retrieved on: 
Tuesday, February 20, 2024

AURORA, Ill., Feb. 20, 2024 /PRNewswire-PRWeb/ -- The Angelman Syndrome Foundation is proud to announce a new collaboration with Cedars-Sinai Guerin Children's to launch a new clinic for patients with Angelman syndrome, a rare neuro-genetic disorder.

Key Points: 
  • The Angelman Syndrome Foundation is proud to announce a new collaboration with Cedars-Sinai Guerin Children's to launch a new clinic for patients with Angelman syndrome, a rare neuro-genetic disorder.
  • AURORA, Ill., Feb. 20, 2024 /PRNewswire-PRWeb/ -- The Angelman Syndrome Foundation is proud to announce a new collaboration with Cedars-Sinai Guerin Children's to launch a new clinic for patients with Angelman syndrome, a rare neuro-genetic disorder.
  • The clinic is led by Cesar Ochoa-Lubinoff, MD, MPH , director of Developmental-Behavioral Pediatrics at Cedars-Sinai Guerin Children's, who previously co-directed the Angelman syndrome clinic at Rush University Medical Center in Chicago.
  • "In my experience, families facing Angelman syndrome are resilient, but they need a supportive medical team in place," Ochoa-Lubinoff said.

The Nation's Largest Black Maternal Health Conference Announces Speaker Lineup and an Award-Winning Film Premiere

Retrieved on: 
Tuesday, February 20, 2024

BOSTON, Feb. 20, 2024 /PRNewswire-PRWeb/ -- Organizers of the 7th Annual Black Maternal Health Conference, the nation's largest convening focused on global Black maternal health outcomes, with nearly 4000 attendees annually, today announced its list of speakers for the April 5 full-day, virtual conference, and the newly added April 6 film premiere of Black Motherhood Through the Lens by filmmaker/producer Dr. Adeiyewunmi (Ade) Osinubi. Hosted by the Center for Black Maternal Health and Reproductive Justice at Tufts University School of Medicine, the 7th Annual Black Maternal Health Conference centers on the role of technology in addressing Black maternal health disparities while creating a one-of-a-kind space to discuss innovations to end the adverse maternal health outcomes experienced by Black Women.

Key Points: 
  • Ahead of Black Maternal Health Week, The 7th Annual Black Maternal Health Conference to Host Tech Experts and Premiere Black Motherhood Through the Lens Documentary
    BOSTON, Feb. 20, 2024 /PRNewswire-PRWeb/ -- Organizers of the 7th Annual Black Maternal Health Conference , the nation's largest convening focused on global Black maternal health outcomes, with nearly 4000 attendees annually, today announced its list of speakers for the April 5 full-day, virtual conference, and the newly added April 6 film premiere of Black Motherhood Through the Lens by filmmaker/producer Dr. Adeiyewunmi (Ade) Osinubi.
  • Hosted by the Center for Black Maternal Health and Reproductive Justice at Tufts University School of Medicine , the 7th Annual Black Maternal Health Conference centers on the role of technology in addressing Black maternal health disparities while creating a one-of-a-kind space to discuss innovations to end the adverse maternal health outcomes experienced by Black Women.
  • The goal of the annual conference is to:
    Identify how health professionals can improve the Black maternal health experience.
  • Discounted early bird registration for the 7th Annual Black Maternal Health Conference is open, with the premiere included virtually for all registrants.

Cell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open Market

Retrieved on: 
Saturday, February 17, 2024

Tevogen Bio Holdings Inc. ('Tevogen Bio') (Nasdaq: TVGN ) celebrated commencement of its public trading by ringing the opening bell at the Nasdaq Stock Exchange in Times Square, New York, on February 15th, 2024.

Key Points: 
  • Tevogen Bio Holdings Inc. ('Tevogen Bio') (Nasdaq: TVGN ) celebrated commencement of its public trading by ringing the opening bell at the Nasdaq Stock Exchange in Times Square, New York, on February 15th, 2024.
  • This major milestone underscored the company's commitment to its valued shareholders and its mission to develop commercially attractive, affordable, genetically unmodified off-the-shelf T cell therapies for large patient populations in virology, oncology, and neurology.
  • “This event not only reconfirmed company’s growth strategy but also reinforced our commitment to our mission.
  • As we embark on this new chapter, we look forward to contributing to the market's vibrancy and delivering value to our shareholders and patients.”

HLM Adds Two New Partners as Firm Celebrates 40 Years of Backing Companies Transforming Healthcare

Retrieved on: 
Thursday, February 15, 2024

Michael and Joseph will be instrumental in identifying new healthcare opportunities, supporting portfolio companies and fundraising for HLM Fund VI.

Key Points: 
  • Michael and Joseph will be instrumental in identifying new healthcare opportunities, supporting portfolio companies and fundraising for HLM Fund VI.
  • Ed Cahill, HLM Partner, commented: “We are excited to have Mike and Joe join HLM.
  • While at MTS, he also founded Elements Health Ventures, a venture capital firm investing in early and growth-stage healthcare technology and services companies.
  • We know they will each make an immediate impact to our firm, our portfolio companies and the next generation of HLM.”

Ozone and PM2.5 Exposure is Associated with Nasal Key Driver Gene Expression in People with Asthma

Retrieved on: 
Thursday, February 15, 2024

MILWAUKEE, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Nasal key driver gene expression representing T-cell mediated immune processes is associated with ozone and fine particulate matter (PM2.5) exposure in people with asthma according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting.

Key Points: 
  • MILWAUKEE, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Nasal key driver gene expression representing T-cell mediated immune processes is associated with ozone and fine particulate matter (PM2.5) exposure in people with asthma according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting.
  • In the study, researchers identified six key driver genes for ozone and three key driver genes for PM2.5 exposure.
  • FGL2, previously reported as a master regulator of asthma, was the most upstream key driver for both ozone and PM2.5.
  • The findings suggest exposure to ozone and PM2.5 in individuals with asthma is associated with nasal key driver gene expression representing T-cell mediated immune processes.